Geneos Wealth Management Inc. Corcept Therapeutics Inc Transaction History
Geneos Wealth Management Inc.
- $3.92 Billion
- Q2 2025
A detailed history of Geneos Wealth Management Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Geneos Wealth Management Inc. holds 77 shares of CORT stock, worth $5,553. This represents 0.0% of its overall portfolio holdings.
Number of Shares
77
Previous 88
12.5%
Holding current value
$5,553
Previous $10,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding CORT
# of Institutions
470Shares Held
82.8MCall Options Held
489KPut Options Held
1.02M-
Black Rock Inc. New York, NY16.5MShares$1.19 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.68MShares$698 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY7.72MShares$557 Million20.11% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.27MShares$452 Million0.65% of portfolio
-
Parallel Advisors, LLC3.87MShares$279 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.72B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...